Patients with device-detected atrial fibrillation and multiple comorbidities do not benefit from anticoagulation: Study

HMN 2024 – by Angelika Leute, Kompetenznetz Vorhofflimmern e.V. (AFNET) Credit: European Heart Journal (2024). DOI: 10.1093/eurheartj/ehae225 In patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding without a clear reduction in stroke. This is the main finding of a sub-analysis of the NOAH–AFNET 6 trial presented by Dr. Julius Nikorowitsch, University Medical […]
Read More